Thursday July 31st, 2014

New 3D models for the study of chronic rhinosinusitis

According to an article published in PLoSOne, researchers from IDIBAPS reconstitute a new nasal respiratory epithelium from mature stem cells of the nasal mucosa of both healthy and inflamed tissue. They have met their objectives by using a technique based in the exposure of primary culture cells to the air.

Read the rest of this entry »

Wednesday July 30th, 2014

Pedro Alonso, New Director of the WHO’s Global Malaria Programme

The World Health Organisation (WHO) has appointed Dr. Pedro Alonso as director of its Global Malaria Programme. Dr Alonso is currently director of the Barcelona Institute for Global Health (ISGlobal), Head of the International Health and Tropical Medicine Unit at the Hospital Clínic of Barcelona, and Professor at the University of Barcelona. He will take up his position at the WHO headquarters in Geneva in October. This appointment to one of the most important posts at the UN health agency is recognition of his work in the field of global health through ISGlobal.

Read the rest of this entry »

Friday July 25th, 2014

Euroimmun acquires the rights of a patent developed by Dr. Graus and Dr. Dalmau for the diagnosis of autoimmune diseases

Dr. Graus and Dr. Dalmau have developed a technology for the diagnosis, prognosis and treatment of patients with an autoimmune disease associated to sleep disorders. It is based on detecting the presence of antibodies against the neuronal protein IGLON5 by immunocytochemistry of transfected cells.

Read the rest of this entry »

No Comments

Categories

Posted in:

Friday July 18th, 2014

IDIBAPS is the Spanish entity with more activities funded by the Innovative Medicines Initiative

The report named “Spanish Participation in the Innovative Medicines Initiative (IMI)” has been recently published by the Center for Industrial Technological Development (CDTI). This report lists the main indicators of participation in 8 of the 11 IMI’s calls supported under the 7th Framework Programme.

Read the rest of this entry »

No Comments
Monday July 14th, 2014

Hospital Clínic and Astellas Pharma promote training in liver transplantation

In the third edition of the Fellowship in Liver Transplant Surgery, Astellas Pharma has exclusively chosen the Liver Surgery and Transplantation Unit at the Hospital Clínic de Barcelona to train a specialist in this field. This year, Dr. Rocío García Pérez, a specialist in General and Digestive Surgery, has been awarded with the fellowship. Dr. Pérez started her formation on May 15th at the department led by Dr. Juan Carlos García-Valdecasas.

Read the rest of this entry »

No Comments

Categories

Posted in:

Tuesday July 8th, 2014

IDIBAPS participates in the Graphene Flagship

In the context of the Graphene Week 2014, the European Commission announced that the Graphene Flagship, one of the largest European research initiatives, is doubling its size and now includes more than 140 organizations from 23 countries. IDIBAPS is one of new 66 partners of the consortium through the team of Maria Victoria Sánchez-Vives, MD, PhD, ICREA Research Professor and team leader of the IDIBAPS group Systems Neuroscience. Professor Sanchez-Vives joins the Neurographene project, coordinated by Rosa Villa, PhD, from the CIBER-BBN Biomonitoring Group at the Barcelona Microelectronics Institute (IMB-CNM), and whose aim is to validate graphene as a brain interface material and to develop devices for both recording neural activity and for brain stimulation. The other partner in this project is the Austrian company Guger Technologies.

Read the rest of this entry »

No Comments
 Page 1 of 54  1  2  3  4  5 » ...  Last »